GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Pharmaceuticals Inc (GREY:WPHM) » Definitions » Total Inventories

Winston Pharmaceuticals (Winston Pharmaceuticals) Total Inventories : $0.03 Mil (As of Mar. 2010)


View and export this data going back to 2006. Start your Free Trial

What is Winston Pharmaceuticals Total Inventories?

Winston Pharmaceuticals's total inventories for the quarter that ended in Mar. 2010 was $0.03 Mil. Winston Pharmaceuticals's average total inventories from the quarter that ended in Dec. 2009 to the quarter that ended in Mar. 2010 was $0.01 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Winston Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Mar. 2010 was $-0.00.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Winston Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2010 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Winston Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2010 was 0.05.


Winston Pharmaceuticals Total Inventories Historical Data

The historical data trend for Winston Pharmaceuticals's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Pharmaceuticals Total Inventories Chart

Winston Pharmaceuticals Annual Data
Trend Sep05 Sep06 Sep07 Dec08 Dec09
Total Inventories
- - - - -

Winston Pharmaceuticals Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.03

Winston Pharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Winston Pharmaceuticals  (GREY:WPHM) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Winston Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2010 is

Net-Net Working Capital Per Share (Q: Mar. 2010 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.678+0.75 * 0+0.5 * 0.029-0.777
-0-0)/77.4089
=-0.00

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Winston Pharmaceuticals's Days Inventory for the three months ended in Mar. 2010 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2010 )/Cost of Goods Sold (Q: Mar. 2010 )*Days in Period
=0.0145/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Winston Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2010 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2010 ) / Average Total Inventories (Q: Mar. 2010 )
=0 / 0.0145
=0.00

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Winston Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2010 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2010 ) / Revenue (Q: Mar. 2010 )
=0.0145 / 0.317
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Winston Pharmaceuticals Total Inventories Related Terms

Thank you for viewing the detailed overview of Winston Pharmaceuticals's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Winston Pharmaceuticals (Winston Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
100 North Fairway Drive, Suite 134, Vernon Hills, IL, USA, 60061
Winston Pharmaceuticals Inc is a pharmaceutical company, which is engaged in the discovery and development of products for pain management. The company focuses on major pain indications such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo- and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Frost Gamma Investments Trust 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137
Subbarao V Uppaluri director 4400 BISCAYNE BOULEVARD, SUITE 1500, MIAMI FL 33137
Curtis Lockshin director 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Glenn L Halpryn director 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Steven Jerry Glauser 10 percent owner 1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Noah M Silver director, officer: Vice President 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Alan Jay Weisberg director, officer: Chief Financial Officer 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Stephen Bittel 10 percent owner 4400 BISCAYNE BOULEVARD SUITE 950 MIAMI FL 33137

Winston Pharmaceuticals (Winston Pharmaceuticals) Headlines

No Headlines